See more : Vigil Neuroscience, Inc. (VIGL) Income Statement Analysis – Financial Results
Complete financial analysis of P3 Health Partners Inc. (PIII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of P3 Health Partners Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- WasteCo Group Limited (WCO.NZ) Income Statement Analysis – Financial Results
- PT Bumi Benowo Sukses Sejahtera Tbk (BBSS.JK) Income Statement Analysis – Financial Results
- RF Acquisition Corp. (RFACW) Income Statement Analysis – Financial Results
- The Allstate Corporation (ALL-PB) Income Statement Analysis – Financial Results
- Imagination Technologies (IGZ) Income Statement Analysis – Financial Results
P3 Health Partners Inc. (PIII)
About P3 Health Partners Inc.
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.27B | 1.05B | 491.06B | 485.54M | 145.48M | 87.70M |
| Cost of Revenue | 1.23B | 1.14B | 668.07M | 485.30M | 141.03M | 0.00 |
| Gross Profit | 31.64M | -95.01M | 490.40B | 243.70K | 4.45M | 87.70M |
| Gross Profit Ratio | 2.50% | -9.05% | 99.86% | 0.05% | 3.06% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 122.36M | 157.30M | 53.39B | 53.39M | 36.42M | 28.54M |
| Selling & Marketing | 3.23M | 5.10M | 1.50B | 1.50M | 801.69K | 1.87M |
| SG&A | 125.60M | 162.40M | 54.89B | 54.89M | 37.23M | 30.41M |
| Other Expenses | 73.97M | 1.13B | 464.76B | 465.77M | 147.79M | -103.73K |
| Operating Expenses | 199.57M | 1.30B | 519.65B | 520.66M | 185.02M | 137.41M |
| Cost & Expenses | 1.43B | 1.30B | 519.65B | 520.66M | 185.02M | 137.41M |
| Interest Income | 0.00 | 11.40M | 0.00 | 2.53M | 2.53M | 0.00 |
| Interest Expense | 15.99M | 11.40M | 10.68M | 2.53M | 2.53M | 0.00 |
| Depreciation & Amortization | 86.68M | 87.29M | 8.72M | 795.17K | 399.18K | 342.20K |
| EBITDA | -81.07M | -1.46B | -184.61M | -28.08M | -39.04M | -49.37M |
| EBITDA Ratio | -6.40% | -14.85% | -6.40% | -7.07% | -26.83% | -56.30% |
| Operating Income | -167.86M | -1.56B | -31.41B | -35.12M | -39.54M | -49.71M |
| Operating Income Ratio | -13.26% | -148.73% | -6.40% | -7.23% | -27.18% | -56.69% |
| Total Other Income/Expenses | -15.87M | 1.22M | -31.22B | -2.82M | -2.44M | -59.50K |
| Income Before Tax | -183.73M | -1.56B | -31.41B | -45.38M | -41.97M | -49.77M |
| Income Before Tax Ratio | -14.51% | -148.60% | -6.40% | -9.35% | -28.85% | -56.76% |
| Income Tax Expense | 2.70M | 1.90M | -31.40B | -4.00M | 2.63M | -6.02M |
| Net Income | -57.77M | -270.13M | -10.08M | -31.41M | -41.97M | -43.80M |
| Net Income Ratio | -4.56% | -25.74% | 0.00% | -6.47% | -28.85% | -49.95% |
| EPS | -0.61 | -6.50 | -0.24 | -0.79 | -0.88 | -0.64 |
| EPS Diluted | -0.20 | -6.50 | -0.24 | -0.79 | -0.88 | -0.64 |
| Weighted Avg Shares Out | 94.89M | 41.58M | 41.58M | 39.53M | 47.59M | 68.16M |
| Weighted Avg Shares Out (Dil) | 294.59M | 41.58M | 41.58M | 39.53M | 47.59M | 68.16M |
P3 Health Partners Schedules Second-Quarter 2023 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for second-quarter 2023 and file its quarterly report on Form...
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating P3 Health Partners Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
NEW YORK , July 10, 2023 /PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of P3 Health Partners Inc....
4 Hot Penny Stocks To Watch This Week
In the world of investment, penny stocks hold a unique position. Often priced at $5 per share or less, these are typically shares of small-cap companies that trade at relatively low prices.
After Soaring 182% Is Time To Ring The Register In P3 Health?
One of the best-performing stocks this month is a company you might have never heard of. Shares of P3 Health Partners NASDAQ: PIII are up 182% so far in May, but a recent trendline break and volume decrease could signal...
Why P3 Healthcare Shares Jumped Wednesday
P3 Health Partners saw revenue rise and net losses fall in the first quarter. The company upgraded adjusted EBITDA predictions for 2023.
4 Penny Stocks To Buy According To Insiders This Quarter
Insiders think these are penny stocks to buy based on recent filings but are they worth the risk? The post 4 Penny Stocks To Buy According To Insiders This Quarter appeared first on Penny Stocks to Buy, Picks, News and...
P3 Health Partners Schedules First-Quarter 2023 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for first-quarter 2023 and file its quarterly report on Form...
P3 Health Partners Announces Date Change for Fourth-Quarter and Full-Year 2022 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announced that it will now release results for fourth-quarter 2022 and full-year ended December 31, 2022 on Friday, March 31,...
P3 Health Partners to Report Fourth-Quarter and Full-Year 2022 Financial Results on March 30
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company expects to release its financial results for fourth-quarter 2022 and full-year ended December 31, 2022 and...
P3 Health Partners Reaffirms 2022 Growth Over 61% And Path To Profitability
P3 Health Partners' guidance breaks the billion-dollar mark in 2022 revenues. P3 Health Partners anticipates that its Adjusted EBITDA will be positive in 2024.
Source: https://incomestatements.info
Category: Stock Reports